Partner News
The section includes updates from partner organizations on related advocacy efforts.
Materials in this section
‘Strong Support, Political Will’ Needed to Achieve Global HBV, HCV Elimination Goals
Globally, and at the continent level, viral hepatitis remains a public health threat through 2030, according to research presented at the International Liver Congress 2022. More
Monitoring of Responses to the Hepatitis B and C Epidemics in EU/EEA Countries – 2020 Data
ECDC provides support to EU/EEA countries in monitoring their progress towards the hepatitis elimination targets and published a report based on the second data collection. More
World Hepatitis Summit 2022 Statement
The participants of the third World Hepatitis Summit called on governments, global health agencies and donors to fund comprehensive hepatitis programs. More
New Global Health Sector Strategy on HIV, Hepatitis and STIs 2022-2030 noted at WHA
The Global Health Sector Strategy aims to reignite momentum in the responses to HIV, hepatitis and STIs that had been eroded by disruptions to services during the COVID-19 pandemic. More
Joint Public Health Symposium - Materials Now Available Online
The Joint Public Health Symposium was held on 31 March 2022 as part of the 31st Conference of the Asian Pacific Association for the Study of the Liver (APASL 2022). More
Gilead’s Claim That Generic Purchase of Sofosbuvir Would Lead to Patent Infringement in Brazil Dismissed
Gilead claims there is a patent infringement by two generic producers and directly asked to block any eventual commercialization of sofosbuvir products by these producers in Brazil. More
Fully Fund the Global Fund: Harm Reduction Brief
Joint briefing on harm reduction and the Global Fund replenishment by Harm Reduction International, EHRA, INPUD and the Global Fund Advocates Network. More
HCV Models of Care – Moving Towards Elimination - Webinar Materials Now Available Online
Webinar hosted by the Hepatitis C Partnership for Control and Treatment (Hepatitis C PACT) in partnership with the WHO Regional Offices for the Western Pacific and South-East Asia. More
Promoting Interventions for Viral Hepatitis and Harm Reduction in PEPFAR COPs - Webinar Materials in English, Portuguese and French
PEPFAR Watch webinar co-hosted by Treatment Action Group, the International Network of People Who Use Drugs, Harm Reduction International, and the World Hepatitis Alliance. More
Call for New Global Long-Acting Technologies CAB Members from Asian, Central African, Eastern European, MENA, and Latin American Countries
TAG and AfroCAB announce an expanded call for a new cross-disease LAT CAB focused on malaria, hepatitis C, and latent TB. Apply now! Applications accepted on a rolling basis. More
